Show simple item record

dc.contributor.authorStorr, J
dc.contributor.authorTwyman, A
dc.contributor.authorZingg, W
dc.contributor.authorDamani, N
dc.contributor.authorKilpatrick, C
dc.contributor.authorReilly, J
dc.contributor.authorPrice, L
dc.contributor.authorEgger, M
dc.contributor.authorGrayson, ML
dc.contributor.authorKelley, E
dc.contributor.authorAllegranzi, B
dc.date.accessioned2020-12-22T03:52:32Z
dc.date.available2020-12-22T03:52:32Z
dc.date.issued2017-01-10
dc.identifierpii: 149
dc.identifier.citationStorr, J., Twyman, A., Zingg, W., Damani, N., Kilpatrick, C., Reilly, J., Price, L., Egger, M., Grayson, M. L., Kelley, E. & Allegranzi, B. (2017). Core components for effective infection prevention and control programmes: new WHO evidence-based recommendations. ANTIMICROBIAL RESISTANCE AND INFECTION CONTROL, 6 (1), https://doi.org/10.1186/s13756-016-0149-9.
dc.identifier.issn2047-2994
dc.identifier.urihttp://hdl.handle.net/11343/257947
dc.description.abstractHealth care-associated infections (HAI) are a major public health problem with a significant impact on morbidity, mortality and quality of life. They represent also an important economic burden to health systems worldwide. However, a large proportion of HAI are preventable through effective infection prevention and control (IPC) measures. Improvements in IPC at the national and facility level are critical for the successful containment of antimicrobial resistance and the prevention of HAI, including outbreaks of highly transmissible diseases through high quality care within the context of universal health coverage. Given the limited availability of IPC evidence-based guidance and standards, the World Health Organization (WHO) decided to prioritize the development of global recommendations on the core components of effective IPC programmes both at the national and acute health care facility level, based on systematic literature reviews and expert consensus. The aim of the guideline development process was to identify the evidence and evaluate its quality, consider patient values and preferences, resource implications, and the feasibility and acceptability of the recommendations. As a result, 11 recommendations and three good practice statements are presented here, including a summary of the supporting evidence, and form the substance of a new WHO IPC guideline.
dc.languageEnglish
dc.publisherBIOMED CENTRAL LTD
dc.rights.urihttps://creativecommons.org/licenses/by/4.0
dc.titleCore components for effective infection prevention and control programmes: new WHO evidence-based recommendations
dc.typeJournal Article
dc.identifier.doi10.1186/s13756-016-0149-9
melbourne.affiliation.departmentDoherty Institute
melbourne.source.titleAntimicrobial Resistance and Infection Control
melbourne.source.volume6
melbourne.source.issue1
dc.rights.licenseCC BY
melbourne.elementsid1183316
melbourne.contributor.authorGrayson, Michael
dc.identifier.eissn2047-2994
melbourne.accessrightsOpen Access


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record